Approval · Notice of Compliance 2536 · 2001
NARDIL TABLETS: Notice of Compliance 2536
Issued January 24, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2536
- Date
- January 24, 2001
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NARDIL TABLETS | 00476552 | Marketed |
Medicinal ingredients
- PHENELZINE SULFATE 15 MG per TAB